Abstract: P947 EZETIMIBE/SIMVASTATIN (E/S) AND ATORVASTATIN (A) TREATMENT MODIFY APOB, LDL-C, AND NON-HDL-C CORRELATIONS IN METABOLIC SYNDROME (MS) PATIENTS AT MODERATELY HIGH RISK(MHR)/HIGH RISK(HR) FOR CHD

Autor: Ballantyne, C, Grundy, S, Hsueh, W, Parving, H, Robinson, J, Rosen, J, Lin, J, Lowe, R, Shah, A, Tershakovec, A
Zdroj: In Atherosclerosis (Supplements) (Component) 2009 10(2):e1094-e1095
Databáze: ScienceDirect
Externí odkaz: